(Q37736016)

22 August 2017

title

National Immunization Technical Advisory Groups (NITAGs): guidance for their establishment and strengthening (English)

1 reference

22 August 2017

0 references

Philippe Duclos

1

1 reference

22 August 2017

language of work or name

English

0 references

publication date

1 April 2010

1 reference

22 August 2017

1 reference

22 August 2017

volume

28 Suppl 1

1 reference

22 August 2017

page(s)

A18-25

1 reference

Decision support in vaccination policies

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.027

A global look at national Immunization Technical Advisory Groups

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.027

Leadership in Immunization: the relevance to Japan of the U.S.A. experience of the Centers for Disease Control and Prevention (CDC) and the Advisory Committee on Immunization Practices (ACIP).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.027

Immunization policy development in the United States: the role of the Advisory Committee on Immunization Practices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.027

Development of immunization policy and its implementation in the United Kingdom

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.027

Canada's National Advisory Committee on Immunization (NACI): evidence-based decision-making on vaccines and immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.027

The structure and function of immunization advisory committees in Western Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.027

National immunization advisory committees of the World Health Organization's European Region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.027

A systematic review of national immunization policy making processes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.027

Financial Conflict of Interest Disclosure and Voting Patterns at Food and Drug Administration Drug Advisory Committee Meetings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.027

[Immunization: process of elaborating guidelines and their evolution in France].

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.027

Developing a vaccination evaluation model to support evidence-based decision making on national immunization programs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.027

An analytical framework for immunization programs in Canada

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.027

A model for enhancing evidence-based capacity to make informed policy decisions on the introduction of new vaccines in the Americas: PAHO's ProVac initiative

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.027

Using population-based routine data for evidence-based health policy decisions: lessons from three examples of setting and evaluating national health policy in Australia, the UK and the USA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.027

Health-care decision-making processes in Latin America: problems and prospects for the use of economic evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.027

The influence of economic evaluation studies on decision making. A European survey. The EUROMET group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.027

BEST PRACTICE IN UNDERTAKING AND REPORTING HEALTH TECHNOLOGY ASSESSMENTS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.027

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.027

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.027

Assessing the methodological quality of published papers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.027

Toward transparency in health technology assessment: a checklist for HTA reports

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.027

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.027

[Global immunization policies and recommendations: objectives and process]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.027

10.1016/J.VACCINE.2010.02.027

7 January 2021

Identifiers

DOI

1 reference

22 August 2017

1 reference